Authors:
HABERL I
SWATONEK H
SCHAUFLER K
ULSPERGER E
WENZL E
THEYER G
HAMILTON G
THALHAMMER T
Citation: I. Haberl et al., P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE IS MODULATED BY PRETREATMENT WITH CHEMOSENSITIZERS IN HCT-8 CARCINOMA-CELLS IN-VITRO, International journal of oncology, 12(5), 1998, pp. 1137-1142
Authors:
HAMILTON G
HABERL I
JAGER W
COSENTINI E
HOFFMANN O
ULSPERGER E
BAUMGARTNER G
WENZL E
THEYER G
Citation: G. Hamilton et al., PHENYLACETATE AND SODIUM SELENITE INCREASE THE CYTOTOXICITY OF CAMPTOTHECINES AGAINST PC3 PROSTATE-CANCER CELLS IN-VITRO, Annals of oncology, 9, 1998, pp. 237-237
Citation: G. Theyer et G. Hamilton, CURRENT STATUS OF INTERMITTENT ANDROGEN SUPPRESSION IN THE TREATMENT OF PROSTATE-CANCER, Urology, 52(3), 1998, pp. 353-359
Authors:
HAMILTON G
HABERL I
COSENTINI E
THEYER G
WENZL E
Citation: G. Hamilton et al., EFFECTS OF THE TUMOR-CELL INVASION INHIBITOR PHENYLACETATE ON CELLULAR PH AND DRUG-SENSITIVITY OF CARCINOMA CELL-LINES, British Journal of Cancer, 78, 1998, pp. 86-86
Citation: G. Theyer et G. Hamilton, INTERMITTENT ANDROGEN SUPPRESSION AS TREA TMENT FOR PATIENTS WITH PROSTATE-CANCER, Aktuelle Urologie, 29(1), 1998, pp. 6-12
Authors:
JAGER W
WINTER O
HALPER B
SALAMON A
SARTORI M
GAJDZIK L
HAMILTON G
THEYER G
GRAF J
THALHAMMER T
Citation: W. Jager et al., MODULATION OF LIVER CANALICULAR TRANSPORT PROCESSES BY THE TYROSINE-KINASE INHIBITOR GENISTEIN - IMPLICATIONS OF GENISTEIN METABOLISM IN THE RAT, Hepatology, 26(6), 1997, pp. 1467-1476
Authors:
GABOR F
WIRTH M
JURKOVICH B
HABERL I
THEYER G
WALCHER G
HAMILTON G
Citation: F. Gabor et al., LECTIN-MEDIATED BIOADHESION - PROTEOLYTIC STABILITY AND BINDING-CHARACTERISTICS OF WHEAT-GERM-AGGLUTININ AND SOLANUM-TUBEROSUM LECTIN ON CACO-2, HT-29 AND HUMAN COLONOCYTES, Journal of controlled release, 49(1), 1997, pp. 27-37
Authors:
THEYER G
HOLUB S
DURER A
ANDERT S
HABERL I
THEYER U
HAMILTON G
Citation: G. Theyer et al., MEASUREMENTS OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC ANTIGEN IN PROSTATE-CANCER PATIENTS UNDER INTERMITTENT ANDROGEN SUPPRESSION THERAPY, British Journal of Cancer, 75(10), 1997, pp. 1515-1518
Authors:
GABOR F
HABERL I
WIRTH M
RICHTER K
THEYER G
BAUMGARTNER G
WENZL E
HAMILTON G
Citation: F. Gabor et al., IN-VITRO ANTITUMOR-ACTIVITY OF MIC2 PROTEIN-DOXORUBICIN CONJUGATES, International journal of oncology, 9(3), 1996, pp. 527-531
Citation: G. Theyer et al., SINGLE-STEP PROCEDURE FOR THE RADICAL RESECTION OF AN ADENOCARCINOMA IN THE DEEP MALE URETHRA, British Journal of Urology, 75(1), 1995, pp. 99-101
Authors:
GABOR F
WOLLMANN K
THEYER G
HABERL I
HAMILTON G
Citation: F. Gabor et al., IN-VITRO ANTIPROLIFERATIVE EFFECTS OF ALBUMIN DOXORUBICIN CONJUGATES AGAINST EWINGS-SARCOMA AND PERIPHERAL NEUROECTODERMAL TUMOR-CELLS, Anticancer research, 14(5A), 1994, pp. 1943-1950
Authors:
THEYER G
SCHIRMBOCK M
THALHAMMER T
SHERWOOD ER
BAUMGARTNER G
HAMILTON G
Citation: G. Theyer et al., ROLE OF THE MDR-1-ENCODED MULTIPLE-DRUG RESISTANCE PHENOTYPE IN PROSTATE-CANCER CELL-LINES, The Journal of urology, 150(5), 1993, pp. 1544-1547